Category Archives: Investment

Heath stock take it on the chin while immuno-oncology IPOs keep a coming.

1. Medical Stock Spotlight 1) Losers far outpaced winners last week with Edge Therapeutics Inc. (Nasdaq:EDGE) nosediving 93% over the week to $1.18. Up until last week, shares of Edge Thera… Read more »

Biotech IPOs rock in 2018. More are storming into the queue.

Steve’s Take: Cutting-edge biotech startups and more established privately-funded but publicly held hopefuls are far and away the winners of the race for deep-pocket investors since New Year’s. I thought… Read more »

Under the radar: Uber launches health platform to get patients to and from appointments–whether or not they have the app or a smartphone!

The News: UBER Technologies Inc. (San Francisco) is launching a new business line called Uber Health that will provide a ride-hailing platform available specifically to healthcare providers, letting clinics, hospitals,… Read more »

Warren Buffett’s bluster about new healthcare venture bound to backfire. Then what?

The News: Warren Buffett says his joint venture with Jeff Bezos and Jamie Dimon is going for something bigger than shaving a few percentage points off healthcare costs. The big… Read more »

Investor Alert: Qiagen grabs Spanish biotech STAT-Dx in quest for new and better diagnostic tests. My personal take.

The News: Molecular diagnostics company Qiagen NV (Hilden DEU) has agreed to acquire biotech STAT-Dx SL (Barcelona) for up to €153 million–over 3 times the total funding the Spanish company has raised… Read more »

Transpacific biotech Engine Biosciences raises $10 million in Southeast Asia’s largest life sciences seed round.

The News: Life sciences startups in Asia just got another shot in the arm with the $10 million investment in Engine Biosciences Pte. Ltd.–a biotech company that’s applying machine learning to… Read more »

Investor alert: Pear Therapeutics hauls-in $50 million Series B after FDA clears first-ever mobile app for substance abuse therapy. What would Warren Buffet think?

The News: The US Food and Drug Administration (FDA) recently cleared for marketing the first prescription mobile medical application to help treat substance use disorders (SUDs) involving alcohol, cocaine, marijuana,… Read more »

French nanocap Sensorion inks deal with Aussie implant-maker Cochlear for €1.6M capital infusion, R&D collaboration. Pearl by the Mediterranean?

The News: Sensorion SA (Montpellier FRA), a tiny biotech company pioneering novel treatments for inner-ear diseases, and Cochlear Ltd. (Sydney), the global leader in implantable hearing devices, in a joint… Read more »

London-based biotech TopiVert, although invisible, intends to shake up Allergan, Shire in the huge dry-eye space.

The News: TopiVert Pharma Ltd., a clinical-stage biotechnology company developing narrow spectrum kinase inhibitors (NSKIs) for chronic inflammatory gastrointestinal (GI) and ocular diseases, has announced results from a Phase 1/2a… Read more »

Netherlands-based, emerging biotech star arGEN-X gives shareholders two doses of great news; stock skyrockets.

The News: arGEN-X SE (Breda NLD) has smoked its target of $150 million for a US stock offering, which will support its cancer and autoimmune disease antibodies through the clinical phases…. Read more »